Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued on Wednesday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Trading Up 10.5 %

Streamline Health Solutions stock opened at $3.25 on Wednesday. The company has a 50 day moving average price of $2.61 and a 200 day moving average price of $5.26. Streamline Health Solutions has a 52 week low of $1.85 and a 52 week high of $9.75. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61. The firm has a market capitalization of $13.72 million, a price-to-earnings ratio of -0.66 and a beta of 1.67.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The firm had revenue of $4.48 million during the quarter.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.